Clinical Trial Update: Long-term Efficacy Study of Sodium Channel Blocker in LQT3 Patients [Phase 2]

View source ↗

Summary

Phase 2 long-term efficacy study of a sodium channel blocker in Long QT Syndrome has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Long Qt Syndrome

Drugs mentioned

• Sodium channel blocker

Snippet

Sponsor: University of Rochester | Conditions: Long QT Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2022-04-07